Fortress Biotech Inc (FBIO)
Healthcare
Biotechnology
2.80 $
-11.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Fortress Biotech Inc (FBIO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 69.5% of the shares are freely tradable; institutional investors hold 24.8%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
24.8%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
22.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
69.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
21.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
33Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Opaleye Management Inc | 3.14 | 1,042,000 | -4.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.91 | 966,030 | +0.0 | 03/31/2026 |
| Shikiar Asset Management Inc | 0.92 | 305,469 | +0.0 | 06/30/2026 |
| Geode Capital Management, LLC | 0.87 | 290,255 | +10.6 | 03/31/2026 |
| GSA Capital Partners LLP | 0.77 | 254,134 | +604.5 | 03/31/2026 |
| Northern Trust Corp | 0.69 | 230,053 | -4.0 | 03/31/2026 |
| Susquehanna International Group, LLP | 0.63 | 210,745 | -8.3 | 03/31/2026 |
| BlackRock Inc | 0.59 | 197,085 | -1.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 2.10 | 697,802 | +0.0 | 06/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.94 | 311,095 | +11.1 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.